Publication|Videos|October 3, 2024

FSP Partnership: A Foundation for Innovation and Patient-Guided Development

Author(s)PAREXEL

Liz Rogers, VP and Head of Global Site and Study Operations at Pfizer, discusses Pfizer's partnership with Parexel and transition to a functional service provider (FSP) model.
  • Transitioning to an FSP model, strategically allocating resources, and leveraging partnerships introduced a more streamlined and efficient model, enhancing resource efficiency and flexibility. The approach has enabled the sponsor (Pfizer) to tap into specialized expertise while maintaining control and oversight of clinical operations.
  • Growing core capabilities in site and study management further enhanced site performance and oversight of quality and compliance. Further strengthening relationships with sites is key to the strategy alongside supporting novel recruitment models, shifting to remote monitoring, and focusing on fewer, higher-performing clinical sites.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!

Related Content